We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,802 hedge funds and large institutions have $249B invested in Johnson & Johnson in 2024 Q2 according to their latest regulatory filings, with 162 funds opening new positions, 1,507 increasing their positions, 1,791 reducing their positions, and 154 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more call options, than puts

Call options by funds: $2.12B | Put options by funds: $1.78B

1.01% more ownership

Funds ownership: 69.87%70.88% (+1%)

5% more first-time investments, than exits

New positions opened: 162 | Existing positions closed: 154

1% less funds holding

Funds holding: 3,8493,802 (-47)

6% less capital invested

Capital invested by funds: $266B → $249B (-$16.5B)

16% less repeat investments, than reductions

Existing positions increased: 1,507 | Existing positions reduced: 1,791

19% less funds holding in top 10

Funds holding in top 10: 204165 (-39)

Holders
3,802
Holders Change
-47
Holders Change %
-1.22%
% of All Funds
54.9%
Holding in Top 10
165
Holding in Top 10 Change
-39
Holding in Top 10 Change %
-19.12%
% of All Funds
2.38%
New
162
Increased
1,507
Reduced
1,791
Closed
154
Calls
$2.12B
Puts
$1.78B
Net Calls
+$333M
Net Calls Change
-$99.1M
Name Holding Trade Value Shares
Change
Change in
Stake
TJHA
3801
Thomas J. Herzfeld Advisors
Florida
$2.19K +$2.23K +15 New
FHC
3802
First Heartland Consultants
Missouri
$1.85K +$136K +916 +8%
NNPTE
3803
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne
Poland
$1.75K
DEM
3804
Disciplined Equity Management
Florida
$1.61K
AIG
3805
American International Group
New York
-$96.5M -609,719 Closed
TPSF
3806
Texas Permanent School Fund
Texas
-$78.7M -497,639 Closed
VMPIC
3807
Varma Mutual Pension Insurance Co
Finland
-$70.6M -446,300 Closed
CSS
3808
Cubist Systematic Strategies
Connecticut
-$31.3M -210,465 Closed
PHK
3809
Point72 Hong Kong
Hong Kong
-$21.1M -133,175 Closed
MLICM
3810
Metropolitan Life Insurance Company (MetLife)
New York
-$15.4M -97,092 Closed
MFAM
3811
Motley Fool Asset Management
Virginia
-$12.9M -81,668 Closed
EW
3812
Evoke Wealth
California
-$12.8M -81,166 Closed
LNC
3813
Lincoln National Corp
Pennsylvania
-$12.2M -77,322 Closed
DCM
3814
Dupont Capital Management
Delaware
-$11.6M -73,248 Closed
PD
3815
Point72 (DIFC)
United Arab Emirates
-$10.8M -72,589 Closed
FNF
3816
Fidelity National Financial
Florida
-$9.25M -58,480 Closed
AIM
3817
Artemis Investment Management
United Kingdom
-$8.58M -54,285 Closed
EWM
3818
Executive Wealth Management
Michigan
-$8.2M -51,988 Closed
RCM
3819
Radnor Capital Management
Pennsylvania
-$8.15M -51,504 Closed
MWM
3820
Meridian Wealth Management
Kentucky
-$7.75M -49,014 Closed
PCH
3821
Polar Capital Holdings
United Kingdom
-$7.56M -47,801 Closed
WAS
3822
WESPAC Advisors SoCal
California
-$7.14M -45,105 Closed
DA
3823
Duality Advisers
Florida
-$6.82M -43,131 Closed
SHFP
3824
Second Half Financial Partners
Florida
-$5.78M -36,527 Closed
SCM
3825
Sitrin Capital Management
California
-$5.29M -33,467 Closed

JNJ Hedge Fund Activity: Q2 2024 in Review

3,802 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2024, worth a combined $249B — down 6.2% from $266B a quarter earlier.

Buyers outnumbered sellers: 162 funds opened new JNJ positions and 154 closed out — a net gain of 8 holders — while 1,507 added to existing stakes and 1,791 trimmed.

The largest buyer was BlackRock, adding an estimated $1.26B. The largest seller was Capital International Investors, cutting an estimated $1.8B.

  • 3,802 institutional investors held Johnson & Johnson (JNJ) as of Q2 2024, down from 3,849 in Q1 2024.
  • Funds reported $249B of Johnson & Johnson stock for Q2 2024, down 6.2% quarter-over-quarter.
  • 162 funds opened new Johnson & Johnson positions in Q2 2024 and 154 closed out, a net change of +8 holders.
  • The largest Johnson & Johnson buyer in Q2 2024 was BlackRock, an estimated $1.26B added.
  • The largest Johnson & Johnson seller in Q2 2024 was Capital International Investors, an estimated $1.8B sold.

Based on aggregated 13F filings for Q2 2024.